CAS: 1393344-72-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Varlilumab REF: TM-T76706CAS: 1393344-72-3 | SDS-PAGE:95% SEC-HPLC:98.65% | 590.00 €~7,344.00 € | Mon 21 Apr 25 |
 | Varlilumab REF: 3D-CLA1048CAS: 1393344-72-3 | - - - | 1,303.00 €~3,633.00 € | Fri 30 May 25 |
Varlilumab
CAS:1393344-72-3
Varlilumab (CDX-1127) is a novel human IgG1 anti-CD27 monoclonal antibody. Varlilumab has antitumor activity and …
Purity:
SDS-PAGE:95% SEC-HPLC:98.65%
Color and Shape:
Liquid
Molecular weight:
146 kDa
Ref: TM-T76706
| 1mg | 590.00 € | ||
| 5mg | 2,015.00 € | ||
| 10mg | 2,717.00 € | ||
| 25mg | 4,019.00 € | ||
| 50mg | 5,444.00 € | ||
| 100mg | 7,344.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
Ref: 3D-CLA1048
| 1mg | 1,303.00 € | ||
| 5mg | 2,220.00 € | ||
| 10mg | 3,633.00 € |
Estimated delivery in United States, on Friday 30 May 2025
